REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioinnova S.A.S. (Colombia)

Main Activities: Medical Equipment and Supplies Manufacturing
Secondary Activities: Other Heavy and Civil Engineering Construction | Fabricated Structural Metal Manufacturing | All Other Professional, Scientific, and Technical Services
Full name: Bioinnova S.A.S. Profile Updated: April 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Bioinnova S.A.S. is based in Colombia. The head office is in Sabaneta. It operates in the Medical Equipment and Supplies Manufacturing industry. Bioinnova S.A.S. was incorporated on June 02, 2017. It currently has a total number of 32 (2026) employees. From the latest financial highlights, Bioinnova S.A.S. reported a net sales revenue increase of 42.46% in 2025. There was a total growth of 10.33% in Bioinnova S.A.S.’s total assets over the same period. In 2025, Bioinnova S.A.S.’s net profit margin decreased by 0.4%.

Headquarters
Cr 48 # 61 Sur 115 Bg 111
Sabaneta; Antioquia;

Contact Details: Purchase the Bioinnova S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Bioinnova S.A.S. report to view the information.
Financial Auditors:
Purchase the Bioinnova S.A.S. report to view the information.
Incorporation Date:
June 02, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Bioinnova S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
42.46%
Total Operating Revenue
42.46%
EBITDA
32.38%
Net Profit/Loss for the Period
32.38%
Total Assets
10.33%
Total Equity
12.46%
Net Profit Margin
-0.4%
Return on Equity (ROE)
1.84%
Quick Ratio
0.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?